Becton Dickinson and Co
Score: Neutral (47)
1 day at current score.
Downgraded from Positive on August 23rd 2017
- This company ranked neutral compared to the Healthcare sector with only 1 positive IHS Markit Category
- Perception of the company's creditworthiness is positive and improving
- ETFs holding this stock are seeing positive inflows but are weakening
- Bearish sentiment is moderate
Short interest | Neutral
Short interest is moderate for BDX with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
ETF/Index ownership | Negative
ETF activity is negative and may be weakening. The net inflows of $3.74 billion over the last one-month into ETFs that hold BDX are among the lowest of the last year and appear to be slowing.
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however.
Credit default swap | Positive
The current level displays a positive indicator with a strengthening bias over the past 1-month. BDX credit default swap spreads are decreasing and near the lowest level of the last three years, which indicates improvement in the market's perception of the company's credit worthiness.
Please send all inquiries related to the report to email@example.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.